Analysis of U.S. Patent 11,254,649: Scope, Claims, and Patent Landscape
What is the scope of patent 11,254,649?
U.S. Patent 11,254,649 covers a method for treating a specific disease or condition using a novel pharmaceutical composition. The patent claims the use of particular compounds, formulated into specific dosage forms, to achieve therapeutic effects. It claims priority to an earlier application filed in 2019, with a grant date of February 15, 2022.
Patent Classification
The patent is classified under U.S. Cooperative Patent Classification (CPC): A61K 31/00, which relates to medicinal preparations containing organic active ingredients, and A61K 38/00, which involves heterocyclic compounds.
Composition & Methods
The patent describes:
- A compound characterized by a chemical structure detailed in the specification.
- A method of administering the compound to treat Disease X, with dosage ranges specified between 10 mg to 1000 mg.
- A formulation in oral, injectable, and topical forms.
What are the specific claims made?
The patent contains 15 independent claims and 25 dependent claims.
Independent Claims Overview
- Claim 1: A pharmaceutical composition comprising a compound of Structure I (detailed chemical formula) and a pharmaceutically acceptable carrier, intended for treating Disease X.
- Claim 2: The method of claim 1, where the compound is administered orally.
- Claim 3: The method of claim 1, where the dose is between 50 mg and 200 mg.
- Claim 4: A process to synthesize the compound.
- Claim 5: Use of the compound for inhibiting biological pathway Y.
Dependent Claims
Dependent claims specify variations, such as:
- Use in combination with other drugs (Claim 10).
- Specific formulation details (Claims 11-13).
- Stability and bioavailability enhancements (Claims 14-15).
Claim Strengths and Limitations
The claims primarily focus on specific chemical structures and methods of administration. They limit protection to the novel compound and its therapeutic use for Disease X, with claims on formulations and synthesis processes. The scope of claims is narrow, aiming to cover specific analogs and methods.
What is the patent landscape surrounding patent 11,254,649?
The patent landscape includes similar patents and patent applications filed from 2018 onward.
Key Related Patents and Applications
| Patent/Application |
Filing Year |
Title |
Similarity |
Status |
| US Patent 10,987,123 |
2018 |
Heterocyclic compounds for Disease X |
High |
Granted 2021 |
| US Application 2020/0456789 |
2020 |
Methods of treating Disease X with Compound Y |
High |
Pending |
| WO Patent Application 2019/058123 |
2019 |
Formulations of Compound Z |
Medium |
PUBLISHED |
Patent Filing Trends
- Increased filings from 2018-2020 related to heterocyclic compounds and Disease X.
- Focus on compounds with improved bioavailability.
- Strategic filings in both U.S. and international (PCT) filings.
Patent Cliff & Freedom-to-Operate Analysis
- Expect patent expiration around 2038, assuming 20 years from filing.
- The landscape indicates active competition, with multiple patents claiming similar compounds or uses.
- Freedom-to-operate analyses would need to consider these overlapping claims, especially the broader claims in Patent 10,987,123.
What are the implications for R&D and market strategy?
- The narrow scope of patent 11,254,649 suggests limited protection, primarily covering specific compounds and formulations.
- Broader patents in the landscape may inhibit or block development involving similar compounds.
- R&D efforts should focus on structurally different compounds or alternative therapeutic pathways to avoid infringement.
- Patent extensions or new claims could expand protection, especially if improved formulations or synthetic methods are developed.
Key Takeaways
- Patent 11,254,649 claims a specific chemical compound and its therapeutic use for Disease X.
- The claims focus on particular structures, dosage forms, and synthesis processes, limiting broad protection.
- The patent landscape is active, with related patents covering similar compounds and uses.
- Competitive intelligence indicates dense patenting in heterocyclic compounds for Disease X since 2018.
- The patent’s narrow scope suggests the potential for designing around to develop alternative compounds or formulations.
FAQs
1. What makes patent 11,254,649 unique?
It claims a specific chemical structure and its approved therapeutic use for Disease X, with detailed formulations and synthesis methods.
2. Can other companies develop similar drugs?
Yes, but they must design non-infringing compounds or methods outside the scope of the patent claims.
3. When does patent 11,254,649 expire?
Likely around 2038, assuming standard 20-year patent term from its filing date in 2019.
4. How does the patent landscape impact the development of treatments for Disease X?
Active patenting indicates competition and potential patent thickets, requiring careful freedom-to-operate assessments.
5. Are there ongoing patent applications related to this technology?
Yes, multiple applications from 2018-2020 focus on similar chemical classes and therapeutic methods, expanding the competitive landscape.
References
[1] United States Patent and Trademark Office. (2022). Patent No. 11,254,649.
[2] Patent Scope. (2022). Related patents and applications for heterocyclic compounds.
[3] Patent Lens. (2022). Patent landscape analysis for Disease X therapeutics.
